Vaccines from BioNTech / Pfizer and Moderna can be combined
Combining vaccines provides similar protection and carries no greater risk of serious side effects than having both vaccines from the same manufacturer.
Published
2021
Showing 0 hits
-
-
Major changes to the assessment of entry quarantine -more countries will turn green
From 5 July, the Norwegian entry restrictions and quarantine rules will be based on the same threshold values as in the EU. The government has made several changes on the basis of the NIPH weekly report, and a considerable number of countries will turn green.
Published
-
COVID-19 certificate ready in EU / EEA version
On Thursday, the Norwegian COVID-19 certificate will be updated so that it can be checked in other EU and EEA countries.
Published
-
COVID-19 certificate for non-digital users ready on Thursday
From Thursday 24 June, people who do not use a smartphone, PC or tablet can receive the COVID-19 certificate by post.
Published
-
Much greater risk of mental disorders in children of low-income parents
Children of parents with the lowest income are three to four times more likely to be diagnosed with mental illness, compared to children of the very richest parents, according to a study from the Norwegian Institute of Public Health.
Published
-
18-year-olds should be vaccinated with 44-year-olds, recommends NIPH
Many people will be offered coronavirus vaccination in the period from May to August 2021. Norway expects to receive 5.7 million vaccine doses during these months.
Published
-
Norwegian-Danish study of rare side effects in connection with AstraZeneca vaccination published
Together with researchers in Denmark, the Norwegian Institute of Public Health has studied the extent of side effects associated with the AstraZeneca vaccine.
Published
-
Vaccination coverage varies with birth country
Vaccination coverage varies with country of birth, according to a new review about the proportion of people vaccinated among immigrant groups. The reasons for the differences are unknown.
Published
-
Extended interval between first and second vaccine dose to vaccinate more people faster
The Ministry of Health and Care Services has decided to extend the interval between the first and second dose of mRNA vaccines against COVID-19 after advice from the NIPH.
Published
-
What can vaccinated people do now?
We have increasingly reliable knowledge that coronavirus vaccines give good protection against becoming ill and from infecting others. We can use that knowledge to ease measures where possible.
Published
-
Norwegian Institute of Public Health's recommendation about AstraZeneca vaccine
The Norwegian Institute of Public Health has recommended stopping further use of the AstraZeneca vaccine (Vaxzevria) in the Coronavirus Immunisation Programme in Norway.
Published
-
Pupils who reach puberty early do better at school
Whether you reach puberty earlier or later can affect the grades you get at secondary school, according to a new study.
Published
-
Heavy metals and essential minerals during pregnancy and associations with ADHD and autism in children
Levels of the heavy metals cadmium, lead, and arsenic and the essential mineral manganese during pregnancy, were associated with increased risk of ADHD and/or autism in the child.
Published
-
Extended pause for AstraZeneca vaccine
The Norwegian Institute of Public Health has decided to extend the pause in the use of the AstraZeneca vaccine because further investigations are necessary.
Published
-
See signs of protection against COVID-19 among those vaccinated
During the last five weeks, a sharp increase in transmission has been seen among most age groups in Norway, but not among the oldest who have the highest vaccination coverage.
Published
-
UK virus variant associated with higher risk of hospital admission
The UK variant of the coronavirus is associated with a higher risk of being admitted to hospital, even among young adults, according to a new study from the Norwegian Institute of Public Health.
Published
-
AstraZeneca vaccine still on hold in Norway
The Norwegian Institute of Public Health (NIPH) will keep use of the AstraZeneca vaccine on hold in Norway and will continue a thorough review of the situation. An update will be provided at the end of week 12.
Published
-
AstraZeneca vaccine: When to consult a doctor
An overview of common side effects after AstraZeneca vaccination, and what people should be alert for, is released by the Norwegian Medicines Agency and the Norwegian Institute of Public Health.
Published
-
Norwegian Medicines Agency notified of blood clots and bleeding in younger people after vaccination with AstraZeneca vaccine
The Norwegian Medicine Agency is asking people who had the AstraZeneca vaccine in the last 14 days and who feel increasingly unwell to be alert.
Published
-
Norwegian Medicines Agency investigating notification about death
The Norwegian Medicines Agency and the Norwegian Institute of Public Health (NIPH) have received a report of a death following vaccination with the AstraZeneca vaccine.
Published
-
Vaccination with AstraZeneca vaccine against COVID-19 put on hold
Following a report in Denmark of a death from a blood clot after receiving the AstraZeneca vaccine, Norway has chosen to suspend vaccination with the AstraZeneca vaccine.
Published
-
Changes in the vaccine strategy
The Norwegian Institute of Public Health will allocate more vaccine doses to areas at particular risk for infection and introduce a new distribution key for vaccines.
Published
-
AstraZeneca vaccine recommended for all over 18 years of age
The Norwegian Institute of Public Health (NIPH) now recommends giving the coronavirus vaccine from AstraZeneca to people over the age of 18.
Published
-
Assisted reproduction affects children’s growth, but only in the first years
Children born after assisted reproduction are smaller at birth, but grow faster during the first years of life, compared to naturally conceived children.
Published
-
The Smittestopp app now works across national borders
Today, the Norwegian Smittestopp app was linked to other infection tracking apps in the EU and EEA.
Published
-
International interest about deaths following coronavirus vaccination
A large proportion of people offered coronavirus vaccination first were the elderly, often with severe underlying diseases. Deaths in connection with vaccination have attracted international interest.
Published
-
Temporary reduction in vaccine supplies to Europe from Pfizer
Pfizer has announced reduced vaccine deliveries starting next week and for some time ahead. The NIPH has an emergency stockpile and can deliver as planned to municipalities and health services.
Published